SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

DA SILVA, Aleksandro Schafer et al. Trypanocidal activity of human plasma on Trypanosoma evansi in mice. Rev. Bras. Parasitol. Vet. [online]. 2012, vol.21, n.1, pp. 55-59. ISSN 1984-2961.  http://dx.doi.org/10.1590/S1984-29612012000100011.

    Colpo CB, Monteiro SG, Stainki DR, Colpo ETB, Henriques GB. Infecção Natural por Trypanosoma evansi em cão no Rio Grande do Sul. Cienc Rural 2005; 35(3): 717-719. http://dx.doi.org/10.1590/S0103-84782005000300038 [ Links ]

    Del Pilar Molina-Portela M, Lugli EB, Recio-Pinto E, Raper J. Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes. Mol Biochem Parasitol 2005; 144(2): 218-226. PMid:16202458. http://dx.doi.org/10.1016/j.molbiopara.2005.08.018 [ Links ]

    Hawking F. The resistance of Trypanosoma congolense, T. vivax and T. evansi to human plasma. Trans R Soc Trop Med Hyg 1978; 72(4): 405-407. http://dx.doi.org/10.1016/0035-9203(78)90136-0 [ Links ]

    Hoare CA. The Trypanosomes of Mammals: A Zoological Monograph. Blackwell: Oxford; 1972. [ Links ]

    Jennings FW, Whitelaw DD, Urquhart GM. The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy. Parasitol 1977; 75(2): 145-153. [ Links ]

    Joshi PP, Shegokar VR, Powar RM, Herder S, Katti R, Salkar HR et al. Human trypanosomosis caused by Trypanosoma evansi in India: The first case report. Am J Trop Med Hyg 2005; 73(3): 491-495. PMid:16172469. [ Links ]

    Otto MA, Da Silva AS, Gressler LT, Dall’Algnol LP, Bottam J, Zanette RA et al. Trypanosoma evansi: therapy with human plasma in infected rats. Comp Clin Pathol 2011; 20(2): 139-141. http://dx.doi.org/10.1007/s00580-010-0968-7 [ Links ]

    Otto MA, Da Silva AS, Gressler LT, Farret MH, Tavares KC, Zanette RA et al. Susceptibility of Trypanosoma evansi to human blood and plasma in infected mice. Vet Parasitol 2010; 168(1-2): 1-4. PMid:19939570. http://dx.doi.org/10.1016/j.vetpar.2009.10.020 [ Links ]

    Otto MA, Faccio L, Soares JF, Soares CDM, Gressler LT, Bess F et al. Plasma de coelhos no controle da infecção por Trypanosoma evansi em ratos. Vet Zootec 2009; 16(2): 379-384. [ Links ]

    Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Pérez-Morga D. The trypanolytic factor of human serum. Nat Rev Microbiol 2006; 4(6): 477-486. http://dx.doi.org/10.1038/nrmicro1428 [ Links ]

    Pays E, Vanhollebeke B. Mutual self-defence: the trypanolytic factor story. Microb infect 2008; 10(9): 985-989. [ Links ]

    Pérez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Homblé F et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 2005; 309(5733): 469-472. PMid:16020735. http://dx.doi.org/10.1126/science.1114566 [ Links ]

    Silva AS, Andrade-Neto OAS, Costa MM, Wolkmer P, Mazzantti CM, Santurio JM et al. Tripanossomose em equinos na região sul do Brasil. Acta Sci Vet 2010; 38(2): 113-120. [ Links ]

    Silva AS, Costa MM, Cargnelutti JF, Lopes STA, Monteiro SG. Alterações bioquímicas em coelhos infectados experimentalmente pelo Trypanosoma evansi. Rev Bras Parasitol Vet2007; 16(1): 43-46. PMid:17588322. [ Links ]

    Silva AS, Costa MM, Cargnelutti JF, Lopes STA, Monteiro SG. Alterações hematológicas em coelhos infectados experimentalmente pelo Trypanosoma evansi. Ciênc Rural 2008a; 38(2): 538-542. http://dx.doi.org/10.1590/S0103-84782008000200040 [ Links ]

    Silva AS, Doyle RL, Monteiro SG. Método de contenção e confecção de esfregaço sanguíneo para pesquisa de hemoparasitas em ratos e camundongos. FZVA 2006; 13(2): 153-157. [ Links ]

    Silva AS, Tochetto C, Zanette RA, Pierezan F, Rissi DR, Santurio JM et al. Aceturato de diminazeno e dipropionato de imidocarb no controle de infecção por Trypanosoma evansi em Rattus norvegicus infectados experimentalmente. Cienc Rural 2008b; 38(5): 1357-1362. http://dx.doi.org/10.1590/S0103-84782008000500025 [ Links ]

    Spinosa HS, Górniak SL, Bernardi MM. Farmacologia aplicada à medicina veterinária. Rio de Janeiro: Guanabara koogan; 1999. [ Links ]

    Tomlinson S, Muranjan M, Nussenzweig V, Raper J. Haptoglobin-related protein and apolipoprotein AI are components of the two trypanolytic factors in human serum. Mol Biochem Parasitol 1997; 86(1): 117-120. PMid:9178275. [ Links ]

    Tuntasuvan D, Jarabrum W, Viseshakul N, Mohkaew K, Borisutsuwan S, Theeraphan A et al. Chemotherapy of surra in horses and mules with diminazene aceturate. Vet Parasitol 2003; 110(2-3): 227-233. http://dx.doi.org/10.1016/S0304-4017(02)00304-7 [ Links ]

    Uche UE, Jones TW, Boid R. Antibody patterns in rabbits showing different levels of susceptibility to an experimental Trypanosoma evansi infection. Acta Trop 1992; 52(2-3): 139-147. http://dx.doi.org/10.1016/0001-706X(92)90030-2 [ Links ]

    Van Meirvenne N, Magnus E, Janssens PG. The effect of normal human serum on trypanosomes of distinct antigenic type (ETat 1 to 12) isolated from a strain of Trypanosoma brucei rhodesiense. Ann Soc Belg Med Trop 1976; 56(1): 55-63. PMid:1015880. [ Links ]

    Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003; 422(6927): 83-87. PMid:12621437. http://dx.doi.org/10.1038/nature01461 [ Links ]

    Vanhollebeke B, Poelvoorde P, Pays A, Joshi PP, Katti R, Jannin JG et al. Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. N Engl J Med 2006; 355(26): 2752-2756. PMid:17192540. http://dx.doi.org/10.1056/NEJMoa063265 [ Links ]

    Ventura RM, Takeda GF, Silva RA, Nunes VL, Buck GA, Teixeira MM. Genetic relatedness among Trypanosoma evansi stocks by random amplification of polymorphic DNA and evaluation of a synapomorphic DNA fragment for species-specific diagnosis. Int J Parasitol 2002; 32(1): 53-63. http://dx.doi.org/10.1016/S0020-7519(01)00314-9 [ Links ]

    Wechsler DS, Kongshavn PA. Further characterization of the curative antibodies in Trypanosoma musculi infection. Infect Immunol 1988; 56(9): 2379-2384. PMid:3410542. PMCid:259576. [ Links ]